Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$24.36 – $34.01
6% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.35B | $3.80B | $3.66B | $4.28B | $3.79B | $3.60B | $3.38B |
| Cost of revenue | $1.49B | $1.41B | $1.29B | $1.59B | $1.46B | $1.20B | $3.16B |
| Gross profit | $2.87B | $2.39B | $2.38B | $2.69B | $2.33B | $2.41B | $223.4M |
| Gross margin | 65.8% | 62.9% | 64.9% | 62.8% | 61.5% | 66.8% | 6.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $228.5M | $138.0M | $290.8M | $318.4M | $107.7M | $243.2M | $226.8M |
| EBITDA | $633.0M | $466.3M | $610.8M | $623.0M | $500.1M | $339.9M | $530.5M |
| Net income | $121.2M | $30.1M | $240.1M | $237.2M | $51.3M | −$95.0M | −$408.6M |
| Net margin | 2.8% | 0.8% | 6.6% | 5.5% | 1.4% | -2.6% | -12.1% |
| EPS (diluted) | 1.52 | 0.36 | 2.79 | 2.76 | 0.60 | -1.12 | -4.83 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.3B | $1.53 | $1.44–$1.59 | 1 |
| 2027 | $3.4B | $1.82 | $1.70–$1.89 | 1 |
| 2028 | $3.6B | $2.22 | $2.08–$2.31 | 1 |
Forward consensus · source: Financial Modeling Prep
IMERYS SA ORD
No one on the platform currently holds IMYSF.
No tracked institution reports a position in IMYSF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-21 | $0.7500 | 2026-05-22 |
| 2025-05-21 | $1.4500 | 2025-05-22 |
| 2024-05-21 | $1.3500 | 2024-05-23 |
No one on the platform has traded IMYSF yet.
| $4.4B |
| — |
| IPGDFIGO Limited | $5.70 | +0.00% | $4.3B | — |
| KPLUFK+S AG | $16.80 | +0.00% | $3.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.6× sales vs its 0.8× historical median P/S.
Fair value ≈ $33.15 · price $24.91 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.